The risk factors of erectile dysfunction for the aged patients with BPH under different treatments

Hanjian Shen,Xiang Wang,Lu Chen,Lianxi Qu,Yuanfang Zhang,Qiang Ding
DOI: https://doi.org/10.3969/j.issn.1008-0848.2009.03.009
2009-01-01
Abstract:Objective To identify the risk factors of erectile dysfunction (ED) for patients with benign prostatic hyperplasia (BPH) under different treatment. Methods The total of 128 BPH patients in our hospital from January of 2006 to October of 2007 were collected in this study. According to different treatment modes, they were divided into two groups: transurethral resection of prostate (TURP) group (n=62) and medication group (n=66). The IIEF-5 assessment were carried out during 6-months follow-up. All 128 patients' data were analyzed by statistic software. Results: The morbidity of ED was 68.60% for all 128 patients before treatment. Six months after TURP, the morbidity of ED for treated patients increased 12.90%. Some patients with prostate volume over 60ml before operation and some with intraoperative capsular perforation during operation were all found to have ED after TURP, and the rate of retrograde ejaculation was 90.91% after operation. For medication group, the morbidity of ED increased 14.70% for patients treated with Finasteride, whereas it decreased 12.50% for patients treated with a i-AR antagonists only. Conclusion The incidence rate of ED for BPH patients after TURP increased 12.90%, especially for some patients with large prostate volume and intraoperative capsular perforation. These above two factors might be risk factors for occurrence of ED. The rate of retrograde ejaculation was 90.91% after operation. Finasteride might have a negative effect on sexual functioning of BPH patients, but a i-AR antagonistTmight have no effect on it. a i-AR antagonists might be considered as the first-line medicine for the treatment of LUTS/BPH with the demand of sexual function.
What problem does this paper attempt to address?